What are the pros and cons of uterine artery embolization?

Photo of patient and nurse after surgery

Uterine artery embolization involves cutting off the blood supply to the fibroid in order to reduce its size. It is an alternative to operations to remove the fibroids (myomectomy) or the womb (hysterectomy).

Fibroids are benign (non-cancerous) growths in or on your womb. They can cause heavy bleeding and pain during menstruation. Sometimes they are also associated with a feeling of pressure against the bladder or bowel.

Fibroids that are causing symptoms can be treated with hormones. But as soon as you stop using them, the fibroids may continue to grow, and the problems can return. Surgery can be a permanent solution. It involves removing the individual fibroids, or the entire womb (uterus).

Another option for dealing with this problem over the long term is uterine artery embolization (also known as uterine fibroid embolization or transcatheter embolization). This procedure is more gentle than the surgical options, and the recovery time is shorter. But the procedure isn't always suitable, and it very often has to be repeated at a later stage.

Uterine fibroids: What are treatment option is suitable for you?

When deciding whether or not to have a treatment, it's a good idea to find out about the pros and cons of the different options first. This decision aid can help here.

What does uterine artery embolization involve?

During uterine artery embolization, the blood vessels that supply the fibroid are closed off under local anesthesia. The doctor makes a small cut in the groin and inserts a thin plastic tube () into the femoral artery. A contrast medium (dye-like substance) is injected so that the blood vessels can be seen on the X-ray. The is then pushed through to the fibroid using the X-ray to guide the way. Tiny plastic particles are then injected into the blood vessels in the fibroid via the . These particles block the blood vessels, stopping the flow of blood to the fibroid.

The procedure lasts between one and two hours. Eight to twelve hours' bed rest are then needed for the cut in the groin to be able to close up again.

A few weeks after this procedure, (MRI) is used to check whether the treatment had the desired effect – in other words, whether the blood supply to the fibroid has been completely cut off. Only then do the fibroids gradually shrink and the symptoms go away. Parts of the fibroid are broken down by the body. The particles remain inside the particles stay in the remaining fibroid tissue, but don't cause any long-term symptoms.

How effective is uterine artery embolization?

Embolization is generally an option for women who have been experiencing severe symptoms because of their fibroids for a long time. These symptoms improve in about 80 to 90 out of 100 women following treatment.

New fibroids may grow afterwards, though. In some women, uterine artery embolization doesn't work well enough, or the positive effect is only temporary. For this reason, about 20 out of 100 women needed further treatment in the first few years after the procedure. They either had the same procedure done again or another type of surgery.

When is uterine artery embolization not suitable?

Some fibroids can't be treated properly using embolization because of their location. They include submucosal fibroids (just under the lining of the womb), and pedunculated subserosal fibroids (on the outside of the womb). Surgery is the preferred treatment for those kinds of fibroids.

There are other reasons not to use embolization, for example if the woman is pregnant or has a genital . Embolization is also not an option for women with a very overactive thyroid because they wouldn't tolerate the iodine in the contrast fluid.

What are the possible side effects?

People often have cramping abdominal pain after embolization. Nausea, vomiting and fever are also possible. These side effects may last for a few days, but they can be treated with medication. In 3 out of 100 women, embolization leads to complications such as an in the womb, damage to blood vessels or deep vein thrombosis in the legs. It is important to seek medical advice if you experience any signs of these problems, like fever or abnormal pain.

Embolization may also make your period stop completely. This happens in about 4 out of 100 women. In about 5 out of 100 women the treated fibroids become detached and leave the body through the vagina.

Does the treatment affect fertility?

Research suggests that uterine artery embolization can affect . One explanation for that is that the tiny plastic particles sometimes mistakenly get into blood vessels in the ovaries, reducing the blood circulation there.

This makes becoming pregnant after embolization somewhat less likely. There is also an increased risk of miscarriage. In studies, this happened in about 20 out of 100 pregnancies. Whether uterine artery embolization is an option if you still want to have a baby depends on what other alternatives you have and how bad the symptoms are.

How effective is uterine artery embolization compared to other procedures?

A small number of studies have compared the outcomes of uterine artery embolization with those of hysterectomy (surgical removal of the womb) and myomectomy (surgical removal of the fibroids). The participants in these studies were women who hadn't been through menopause and had heavy menstrual bleeding because of their fibroids.

Uterine artery embolization compared to myomectomy

Uterine artery embolization and myomectomy were compared based on the following:

  • Quality of life: Quality of life was better after myomectomy than it was after uterine artery embolization.
  • Symptoms: The women had fewer symptoms after myomectomy compared to embolization.
  • Satisfaction with the treatment after two years: The participants in both groups were similarly satisfied with the outcome of the treatment.
  • Length of time spent in the hospital: Women who had uterine artery embolization recovered quicker and were able to leave the hospital about one day earlier than those who had a myomectomy.
  • Fertility: 23 out of 100 women had children after the embolization procedure, compared to 48 out of 100 after a myomectomy.
  • Serious complications: These occurred in about 1 out of 100 women in each group.
  • Need for further treatment: 16 out of 100 women were treated again within two years of an initial embolization procedure, and 7 out of 100 women were treated again after a myomectomy.

But these results should be interpreted with caution. There isn't enough research comparing the advantages and disadvantages of uterine artery embolization with those of myomectomy. One likely benefit of uterine artery embolization is the faster recovery after the procedure. Plus, general anesthesia is not needed. It may be harder to have a child after embolization than after a myomectomy. Women are also more likely to need further treatments after embolization. Both procedures probably relieve the symptoms equally well in the short term. There is no research into whether this is also the case in the long term.

Uterine artery embolization compared to hysterectomy

Uterine artery embolization and hysterectomy were compared in the studies based on the following:

  • Satisfaction with the treatment after two years: The participants in both groups were similarly satisfied with the outcome of the treatment.
  • Length of time spent in the hospital: Women who had uterine artery embolization recovered quicker, and were able to leave the hospital about three days earlier than those who had had a hysterectomy.
  • Serious complications: These occurred in about 1 out of 100 women in each group.
  • Need for further treatment: 22 out of 100 women were treated again within two years of an initial embolization procedure, and 9 out of 100 women were treated again after a hysterectomy.

One main advantage of embolization is that the womb is not removed. The treatment and recovery time is also shorter. Plus, general anesthesia is not needed. But further treatments are more likely to be needed after embolization. Side effects are also more common shortly after this treatment. No research has compared the long-term effects of the two treatments.

Akhatova A, Aimagambetova G, Bapayeva G et al. Reproductive and Obstetric Outcomes after UAE, HIFU, and TFA of Uterine Fibroids: Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2023; 20(5): 4480.

Fatima K, Ansari HW, Ejaz A et al. Uterine artery embolization versus myomectomy: a systematic review and meta-analysis. SAGE Open Med 2024; 12: 20503121241236141.

Ghanaati H, Sanaati M, Shakiba M et al. Pregnancy and its Outcomes in Patients After Uterine Fibroid Embolization: A Systematic Review and Meta-Analysis. Cardiovasc Intervent Radiol 2020; 43(8): 1122-1133.

Gupta JK, Sinha A, Lumsden MA et al. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 2014; (12): CD005073.

Hartmann KE, Fonnesbeck C, Surawicz T et al. Management of Uterine Fibroids. (AHRQ Comparative Effectiveness Reviews; No. 195). 2017.

Institute for Quality and Efficiency in Health Care (IQWiG, Germany). UAE and MRgFUS versus myoma enucleation. Evidence search for the S3 guideline on diagnosis and treatment of benign diseases of the uterus; Commission V21-08D. 2023.

Sandberg EM, Tummers FH, Cohen SL et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis. Fertil Steril 2018; 109(4): 698-707.

Toor SS, Jaberi A, Macdonald DB et al. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. AJR Am J Roentgenol 2012; 199(5): 1153-1163.

IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.

Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.

Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.

Comment on this page

What would you like to share with us?

We welcome any feedback and ideas - either via our form or by gi-kontakt@iqwig.de. We will review, but not publish, your ratings and comments. Your information will of course be treated confidentially. Fields marked with an asterisk (*) are required fields.

Please note that we do not provide individual advice on matters of health. You can read about where to find help and support in Germany in our information “How can I find self-help groups and information centers?

Über diese Seite

Updated on June 24, 2025

Next planned update: 2028

Publisher:

Institute for Quality and Efficiency in Health Care (IQWiG, Germany)

Stay informed

Subscribe to our newsletter or newsfeed. You can find our growing collection of films on YouTube.